Pregnancy Test Kit Market - Growth Drivers and Challenges
Growth Drivers
- Ease use of kits: Pregnancy test kits are ease to use, and most of the women find and prefer them a convenient technique to check and analyze their pregnancy status at the initial stage. Most of the women, both in developed and developing countries, prefer pregnancy test kits as the initial and a comfort method, and hence avoid hospital visits and save time. According to the NLM article published in August 2023, the pregnancy test kits provide 99% accurate results, and some test kit brands provide the number of weeks of in pregnancy. This test at home usually takes less than 3 minutes to check the results, as per the first response pregnancy kit product.
- Rising pregnancy rates: As per the World Family Planning 2022 report, in 41 countries, nearly half of women who want to avoid pregnancies use modern pregnancy test kits. Further in Sub-Saharan Africa, 22 countries are exhibiting this modern method, contributing to the demand for the market. Further, the awareness of the intended pregnancies among the female population drives the demand for the use of these kits. Government-led initiatives and campaigns are promoting awareness and surging the adoption of test kits in emerging regions.
- Increased accessibility driving market: The pregnancy test kits are available in pharmacies, supermarkets, and e-commerce platforms, hence surging the market growth. Companies like Amazon, Walmart, and CVS provide options for online purchases. Further, most of the women feel compelled to buy pregnancy test kits online. As per the WRC report published in May 2024, the cost of pregnancy test kits usually ranges from USD 1 to USD 15. Further, in developing countries, low-cost test kits are provided to the local market in pharmacies to increase access among the young and rural population.
Annual Growth Rate of Female Population Demanding the Market
|
Year |
Rural |
Urban |
Total Population |
Average Annual Exponential Growth Rate |
|
2001 |
360.95 |
135.57 |
496.51 |
1.99 |
|
2011 |
405.97 |
181.62 |
587.58 |
1.69 |
|
2016 |
422.80 |
204.09 |
626.89 |
1.30 |
|
2021 |
436.25 |
226.13 |
662.38 |
1.10 |
|
2026 |
446.47 |
247.36 |
693.83 |
0.93 |
Source: MOSPI,2024
Challenges
- Mistrust in the accuracy: As per the frontiers report, many illiterate women and a lack of trust in the accuracy issues were not motivated to use the pregnancy test kits. The report has also stated that trust issue is a great barrier to self-testing. Some women also think that the kits give abnormal results and don’t give an exact response. Further, cultural beliefs and a lack of awareness about how the kits work further contribute to disbelief. Without proper education and reassurance from healthcare providers, women may not rely completely on home pregnancy tests to confirm their pregnancies.
Pregnancy Test Kit Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
5.5% |
|
Base Year Market Size (2025) |
USD 2 billion |
|
Forecast Year Market Size (2035) |
USD 3.4 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of pregnancy test kit is evaluated at USD 2 billion.
The pregnancy test kit market size was valued at USD 2 billion in 2025 and is projected to reach USD 3.4 billion by the end of 2035, rising at a CAGR of 5.5% during the forecast period, i.e., 2026-2035.
The pregnancy test kit market is dominating the Asia Pacific region and is anticipated to hold the market share of 30.8% at a CAGR of 7.9% by 2035.
The major players in the market are SPD Swiss Precision Diagnostics GmbH, Church & Dwight Co., Inc., ACON Laboratories, Inc., Piramal Healthcare, Rohto Pharmaceutical Co., Ltd., Prestige Brands Holdings, Inc., JAL Innovation (JAL Group), Artron Laboratories Inc., BioSure (UK) Ltd., BTNX Inc., InTec Products, Inc., Atlas Medical, Nulife Care, Everlywell, Inc., PTS Diagnostics, Hangzhou AllTest Biotech Co., Ltd., Medisign Diagnostic, Green Cross Medical Science, LifeSign LLC, Abon Biopharm Co., Ltd.